nodes	percent_of_prediction	percent_of_DWPC	metapath
Clavulanate—Induration—Paclitaxel—lung cancer	0.0136	0.0136	CcSEcCtD
Clavulanate—Hypokalaemia—Crizotinib—lung cancer	0.0128	0.0128	CcSEcCtD
Clavulanate—Pseudomembranous colitis—Paclitaxel—lung cancer	0.0123	0.0123	CcSEcCtD
Clavulanate—Hypokalaemia—Gefitinib—lung cancer	0.0116	0.0116	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Pemetrexed—lung cancer	0.0115	0.0115	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Gefitinib—lung cancer	0.0115	0.0115	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Pemetrexed—lung cancer	0.00979	0.00979	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Gefitinib—lung cancer	0.00973	0.00973	CcSEcCtD
Clavulanate—Hepatitis—Pemetrexed—lung cancer	0.00887	0.00887	CcSEcCtD
Clavulanate—Haemoglobin—Gefitinib—lung cancer	0.00885	0.00885	CcSEcCtD
Clavulanate—Haemorrhage—Gefitinib—lung cancer	0.00881	0.00881	CcSEcCtD
Clavulanate—Hepatitis—Gefitinib—lung cancer	0.00881	0.00881	CcSEcCtD
Clavulanate—Erythema multiforme—Pemetrexed—lung cancer	0.00838	0.00838	CcSEcCtD
Clavulanate—Erythema multiforme—Gefitinib—lung cancer	0.00833	0.00833	CcSEcCtD
Clavulanate—Thrombophlebitis—Vinorelbine—lung cancer	0.0076	0.0076	CcSEcCtD
Clavulanate—Leukopenia—Crizotinib—lung cancer	0.00756	0.00756	CcSEcCtD
Clavulanate—Haemoglobin—Teniposide—lung cancer	0.00722	0.00722	CcSEcCtD
Clavulanate—Haemorrhage—Teniposide—lung cancer	0.00718	0.00718	CcSEcCtD
Clavulanate—Hypokalaemia—Erlotinib—lung cancer	0.00693	0.00693	CcSEcCtD
Clavulanate—Leukopenia—Pemetrexed—lung cancer	0.00691	0.00691	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Erlotinib—lung cancer	0.00685	0.00685	CcSEcCtD
Clavulanate—Anaphylactic shock—Pemetrexed—lung cancer	0.0063	0.0063	CcSEcCtD
Clavulanate—Thrombophlebitis—Irinotecan—lung cancer	0.00627	0.00627	CcSEcCtD
Clavulanate—Thrombocytopenia—Pemetrexed—lung cancer	0.00617	0.00617	CcSEcCtD
Clavulanate—Thrombocytopenia—Gefitinib—lung cancer	0.00613	0.00613	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Erlotinib—lung cancer	0.00582	0.00582	CcSEcCtD
Clavulanate—Leukopenia—Teniposide—lung cancer	0.0056	0.0056	CcSEcCtD
Clavulanate—Haemoglobin—Vinblastine—lung cancer	0.00551	0.00551	CcSEcCtD
Clavulanate—Haemorrhage—Vinblastine—lung cancer	0.00548	0.00548	CcSEcCtD
Clavulanate—Pain—Pemetrexed—lung cancer	0.00539	0.00539	CcSEcCtD
Clavulanate—Pain—Gefitinib—lung cancer	0.00535	0.00535	CcSEcCtD
Clavulanate—Haemoglobin—Topotecan—lung cancer	0.00535	0.00535	CcSEcCtD
Clavulanate—Haemorrhage—Topotecan—lung cancer	0.00532	0.00532	CcSEcCtD
Clavulanate—Haemoglobin—Erlotinib—lung cancer	0.00529	0.00529	CcSEcCtD
Clavulanate—Haemorrhage—Erlotinib—lung cancer	0.00527	0.00527	CcSEcCtD
Clavulanate—Hepatitis—Erlotinib—lung cancer	0.00527	0.00527	CcSEcCtD
Clavulanate—Swelling—Etoposide—lung cancer	0.00512	0.00512	CcSEcCtD
Clavulanate—Thrombophlebitis—Paclitaxel—lung cancer	0.00511	0.00511	CcSEcCtD
Clavulanate—Swelling—Paclitaxel—lung cancer	0.00502	0.00502	CcSEcCtD
Clavulanate—Urticaria—Pemetrexed—lung cancer	0.005	0.005	CcSEcCtD
Clavulanate—Thrombocytopenia—Teniposide—lung cancer	0.005	0.005	CcSEcCtD
Clavulanate—Erythema multiforme—Erlotinib—lung cancer	0.00498	0.00498	CcSEcCtD
Clavulanate—Urticaria—Gefitinib—lung cancer	0.00497	0.00497	CcSEcCtD
Clavulanate—Hypokalaemia—Irinotecan—lung cancer	0.00494	0.00494	CcSEcCtD
Clavulanate—Hypokalaemia—Gemcitabine—lung cancer	0.00481	0.00481	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Gemcitabine—lung cancer	0.00476	0.00476	CcSEcCtD
Clavulanate—Diarrhoea—Crizotinib—lung cancer	0.00472	0.00472	CcSEcCtD
Clavulanate—Hypersensitivity—Pemetrexed—lung cancer	0.00464	0.00464	CcSEcCtD
Clavulanate—Hypersensitivity—Gefitinib—lung cancer	0.00461	0.00461	CcSEcCtD
Clavulanate—Hypokalaemia—Cisplatin—lung cancer	0.00449	0.00449	CcSEcCtD
Clavulanate—Pruritus—Pemetrexed—lung cancer	0.00446	0.00446	CcSEcCtD
Clavulanate—Pruritus—Gefitinib—lung cancer	0.00443	0.00443	CcSEcCtD
Clavulanate—Vomiting—Crizotinib—lung cancer	0.00438	0.00438	CcSEcCtD
Clavulanate—Rash—Crizotinib—lung cancer	0.00435	0.00435	CcSEcCtD
Clavulanate—Dermatitis—Crizotinib—lung cancer	0.00434	0.00434	CcSEcCtD
Clavulanate—Thrombophlebitis—Docetaxel—lung cancer	0.00433	0.00433	CcSEcCtD
Clavulanate—Diarrhoea—Pemetrexed—lung cancer	0.00431	0.00431	CcSEcCtD
Clavulanate—Diarrhoea—Gefitinib—lung cancer	0.00428	0.00428	CcSEcCtD
Clavulanate—Leukopenia—Vinblastine—lung cancer	0.00427	0.00427	CcSEcCtD
Clavulanate—Swelling—Docetaxel—lung cancer	0.00425	0.00425	CcSEcCtD
Clavulanate—Leukopenia—Topotecan—lung cancer	0.00415	0.00415	CcSEcCtD
Clavulanate—Convulsion—Vinblastine—lung cancer	0.00413	0.00413	CcSEcCtD
Clavulanate—Nausea—Crizotinib—lung cancer	0.00409	0.00409	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Etoposide—lung cancer	0.00407	0.00407	CcSEcCtD
Clavulanate—Urticaria—Teniposide—lung cancer	0.00405	0.00405	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Gemcitabine—lung cancer	0.00404	0.00404	CcSEcCtD
Clavulanate—Hypokalaemia—Paclitaxel—lung cancer	0.00403	0.00403	CcSEcCtD
Clavulanate—Vomiting—Pemetrexed—lung cancer	0.004	0.004	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Paclitaxel—lung cancer	0.00399	0.00399	CcSEcCtD
Clavulanate—Vomiting—Gefitinib—lung cancer	0.00398	0.00398	CcSEcCtD
Clavulanate—Rash—Pemetrexed—lung cancer	0.00397	0.00397	CcSEcCtD
Clavulanate—Dermatitis—Pemetrexed—lung cancer	0.00397	0.00397	CcSEcCtD
Clavulanate—Rash—Gefitinib—lung cancer	0.00395	0.00395	CcSEcCtD
Clavulanate—Dermatitis—Gefitinib—lung cancer	0.00394	0.00394	CcSEcCtD
Clavulanate—Thrombocytopenia—Vinblastine—lung cancer	0.00381	0.00381	CcSEcCtD
Clavulanate—Anaphylactic shock—Topotecan—lung cancer	0.00378	0.00378	CcSEcCtD
Clavulanate—Haemoglobin—Irinotecan—lung cancer	0.00377	0.00377	CcSEcCtD
Clavulanate—Hypersensitivity—Teniposide—lung cancer	0.00376	0.00376	CcSEcCtD
Clavulanate—Haemorrhage—Irinotecan—lung cancer	0.00376	0.00376	CcSEcCtD
Clavulanate—Nausea—Pemetrexed—lung cancer	0.00374	0.00374	CcSEcCtD
Clavulanate—Nausea—Gefitinib—lung cancer	0.00372	0.00372	CcSEcCtD
Clavulanate—Thrombocytopenia—Topotecan—lung cancer	0.0037	0.0037	CcSEcCtD
Clavulanate—Haemoglobin—Gemcitabine—lung cancer	0.00368	0.00368	CcSEcCtD
Clavulanate—Jaundice cholestatic—Doxorubicin—lung cancer	0.00367	0.00367	CcSEcCtD
Clavulanate—Thrombocytopenia—Erlotinib—lung cancer	0.00366	0.00366	CcSEcCtD
Clavulanate—Haemorrhage—Gemcitabine—lung cancer	0.00366	0.00366	CcSEcCtD
Clavulanate—Pruritus—Teniposide—lung cancer	0.00361	0.00361	CcSEcCtD
Clavulanate—Leukopenia—Vinorelbine—lung cancer	0.00355	0.00355	CcSEcCtD
Clavulanate—Diarrhoea—Teniposide—lung cancer	0.00349	0.00349	CcSEcCtD
Clavulanate—Erythema multiforme—Gemcitabine—lung cancer	0.00346	0.00346	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Etoposide—lung cancer	0.00345	0.00345	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Paclitaxel—lung cancer	0.00338	0.00338	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Docetaxel—lung cancer	0.00338	0.00338	CcSEcCtD
Clavulanate—Pain—Vinblastine—lung cancer	0.00333	0.00333	CcSEcCtD
Clavulanate—Vomiting—Teniposide—lung cancer	0.00324	0.00324	CcSEcCtD
Clavulanate—Anaphylactic shock—Vinorelbine—lung cancer	0.00323	0.00323	CcSEcCtD
Clavulanate—Pain—Topotecan—lung cancer	0.00323	0.00323	CcSEcCtD
Clavulanate—Rash—Teniposide—lung cancer	0.00322	0.00322	CcSEcCtD
Clavulanate—Dermatitis—Teniposide—lung cancer	0.00321	0.00321	CcSEcCtD
Clavulanate—Pain—Erlotinib—lung cancer	0.0032	0.0032	CcSEcCtD
Clavulanate—Thrombocytopenia—Vinorelbine—lung cancer	0.00317	0.00317	CcSEcCtD
Clavulanate—Thrombophlebitis—Methotrexate—lung cancer	0.00312	0.00312	CcSEcCtD
Clavulanate—Haemoglobin—Paclitaxel—lung cancer	0.00308	0.00308	CcSEcCtD
Clavulanate—Haemorrhage—Paclitaxel—lung cancer	0.00306	0.00306	CcSEcCtD
Clavulanate—Nausea—Teniposide—lung cancer	0.00303	0.00303	CcSEcCtD
Clavulanate—Urticaria—Topotecan—lung cancer	0.003	0.003	CcSEcCtD
Clavulanate—Erythema multiforme—Etoposide—lung cancer	0.00295	0.00295	CcSEcCtD
Clavulanate—Leukopenia—Irinotecan—lung cancer	0.00293	0.00293	CcSEcCtD
Clavulanate—Erythema multiforme—Paclitaxel—lung cancer	0.0029	0.0029	CcSEcCtD
Clavulanate—Hypersensitivity—Vinblastine—lung cancer	0.00287	0.00287	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Docetaxel—lung cancer	0.00287	0.00287	CcSEcCtD
Clavulanate—Leukopenia—Gemcitabine—lung cancer	0.00285	0.00285	CcSEcCtD
Clavulanate—Hypersensitivity—Topotecan—lung cancer	0.00279	0.00279	CcSEcCtD
Clavulanate—Pain—Vinorelbine—lung cancer	0.00277	0.00277	CcSEcCtD
Clavulanate—Thrombophlebitis—Doxorubicin—lung cancer	0.00271	0.00271	CcSEcCtD
Clavulanate—Pruritus—Topotecan—lung cancer	0.00268	0.00268	CcSEcCtD
Clavulanate—Anaphylactic shock—Irinotecan—lung cancer	0.00267	0.00267	CcSEcCtD
Clavulanate—Diarrhoea—Vinblastine—lung cancer	0.00266	0.00266	CcSEcCtD
Clavulanate—Leukopenia—Cisplatin—lung cancer	0.00266	0.00266	CcSEcCtD
Clavulanate—Pruritus—Erlotinib—lung cancer	0.00265	0.00265	CcSEcCtD
Clavulanate—Thrombocytopenia—Irinotecan—lung cancer	0.00261	0.00261	CcSEcCtD
Clavulanate—Haemoglobin—Docetaxel—lung cancer	0.00261	0.00261	CcSEcCtD
Clavulanate—Anaphylactic shock—Gemcitabine—lung cancer	0.0026	0.0026	CcSEcCtD
Clavulanate—Haemorrhage—Docetaxel—lung cancer	0.0026	0.0026	CcSEcCtD
Clavulanate—Hepatitis—Docetaxel—lung cancer	0.0026	0.0026	CcSEcCtD
Clavulanate—Diarrhoea—Topotecan—lung cancer	0.00259	0.00259	CcSEcCtD
Clavulanate—Convulsion—Cisplatin—lung cancer	0.00257	0.00257	CcSEcCtD
Clavulanate—Urticaria—Vinorelbine—lung cancer	0.00257	0.00257	CcSEcCtD
Clavulanate—Diarrhoea—Erlotinib—lung cancer	0.00256	0.00256	CcSEcCtD
Clavulanate—Thrombocytopenia—Gemcitabine—lung cancer	0.00254	0.00254	CcSEcCtD
Clavulanate—Vomiting—Vinblastine—lung cancer	0.00248	0.00248	CcSEcCtD
Clavulanate—Erythema multiforme—Docetaxel—lung cancer	0.00245	0.00245	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Methotrexate—lung cancer	0.00244	0.00244	CcSEcCtD
Clavulanate—Leukopenia—Etoposide—lung cancer	0.00243	0.00243	CcSEcCtD
Clavulanate—Anaphylactic shock—Cisplatin—lung cancer	0.00242	0.00242	CcSEcCtD
Clavulanate—Vomiting—Topotecan—lung cancer	0.0024	0.0024	CcSEcCtD
Clavulanate—Leukopenia—Paclitaxel—lung cancer	0.00239	0.00239	CcSEcCtD
Clavulanate—Rash—Topotecan—lung cancer	0.00238	0.00238	CcSEcCtD
Clavulanate—Hypersensitivity—Vinorelbine—lung cancer	0.00238	0.00238	CcSEcCtD
Clavulanate—Dermatitis—Topotecan—lung cancer	0.00238	0.00238	CcSEcCtD
Clavulanate—Vomiting—Erlotinib—lung cancer	0.00238	0.00238	CcSEcCtD
Clavulanate—Thrombocytopenia—Cisplatin—lung cancer	0.00237	0.00237	CcSEcCtD
Clavulanate—Rash—Erlotinib—lung cancer	0.00236	0.00236	CcSEcCtD
Clavulanate—Dermatitis—Erlotinib—lung cancer	0.00236	0.00236	CcSEcCtD
Clavulanate—Convulsion—Etoposide—lung cancer	0.00236	0.00236	CcSEcCtD
Clavulanate—Eosinophilia—Methotrexate—lung cancer	0.00231	0.00231	CcSEcCtD
Clavulanate—Nausea—Vinblastine—lung cancer	0.00231	0.00231	CcSEcCtD
Clavulanate—Convulsion—Paclitaxel—lung cancer	0.00231	0.00231	CcSEcCtD
Clavulanate—Pruritus—Vinorelbine—lung cancer	0.00229	0.00229	CcSEcCtD
Clavulanate—Pain—Irinotecan—lung cancer	0.00228	0.00228	CcSEcCtD
Clavulanate—Nausea—Topotecan—lung cancer	0.00225	0.00225	CcSEcCtD
Clavulanate—Pain—Gemcitabine—lung cancer	0.00222	0.00222	CcSEcCtD
Clavulanate—Nausea—Erlotinib—lung cancer	0.00222	0.00222	CcSEcCtD
Clavulanate—Anaphylactic shock—Etoposide—lung cancer	0.00222	0.00222	CcSEcCtD
Clavulanate—Diarrhoea—Vinorelbine—lung cancer	0.00221	0.00221	CcSEcCtD
Clavulanate—Anaphylactic shock—Paclitaxel—lung cancer	0.00218	0.00218	CcSEcCtD
Clavulanate—Thrombocytopenia—Etoposide—lung cancer	0.00217	0.00217	CcSEcCtD
Clavulanate—Hypokalaemia—Doxorubicin—lung cancer	0.00213	0.00213	CcSEcCtD
Clavulanate—Thrombocytopenia—Paclitaxel—lung cancer	0.00213	0.00213	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.00211	0.00211	CcSEcCtD
Clavulanate—Pain—Cisplatin—lung cancer	0.00207	0.00207	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.00207	0.00207	CcSEcCtD
Clavulanate—Vomiting—Vinorelbine—lung cancer	0.00206	0.00206	CcSEcCtD
Clavulanate—Rash—Vinorelbine—lung cancer	0.00204	0.00204	CcSEcCtD
Clavulanate—Dermatitis—Vinorelbine—lung cancer	0.00204	0.00204	CcSEcCtD
Clavulanate—Leukopenia—Docetaxel—lung cancer	0.00202	0.00202	CcSEcCtD
Clavulanate—Eosinophilia—Doxorubicin—lung cancer	0.002	0.002	CcSEcCtD
Clavulanate—Hypersensitivity—Irinotecan—lung cancer	0.00197	0.00197	CcSEcCtD
Clavulanate—Convulsion—Docetaxel—lung cancer	0.00196	0.00196	CcSEcCtD
Clavulanate—Nausea—Vinorelbine—lung cancer	0.00192	0.00192	CcSEcCtD
Clavulanate—Pain—Etoposide—lung cancer	0.0019	0.0019	CcSEcCtD
Clavulanate—Haemoglobin—Methotrexate—lung cancer	0.00188	0.00188	CcSEcCtD
Clavulanate—Hepatitis—Methotrexate—lung cancer	0.00187	0.00187	CcSEcCtD
Clavulanate—Haemorrhage—Methotrexate—lung cancer	0.00187	0.00187	CcSEcCtD
Clavulanate—Pain—Paclitaxel—lung cancer	0.00186	0.00186	CcSEcCtD
Clavulanate—Anaphylactic shock—Docetaxel—lung cancer	0.00184	0.00184	CcSEcCtD
Clavulanate—Pruritus—Gemcitabine—lung cancer	0.00184	0.00184	CcSEcCtD
Clavulanate—Diarrhoea—Irinotecan—lung cancer	0.00183	0.00183	CcSEcCtD
Clavulanate—Thrombocytopenia—Docetaxel—lung cancer	0.00181	0.00181	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.00179	0.00179	CcSEcCtD
Clavulanate—Hypersensitivity—Cisplatin—lung cancer	0.00178	0.00178	CcSEcCtD
Clavulanate—Diarrhoea—Gemcitabine—lung cancer	0.00178	0.00178	CcSEcCtD
Clavulanate—Erythema multiforme—Methotrexate—lung cancer	0.00177	0.00177	CcSEcCtD
Clavulanate—Urticaria—Etoposide—lung cancer	0.00176	0.00176	CcSEcCtD
Clavulanate—Urticaria—Paclitaxel—lung cancer	0.00173	0.00173	CcSEcCtD
Clavulanate—Vomiting—Irinotecan—lung cancer	0.0017	0.0017	CcSEcCtD
Clavulanate—Rash—Irinotecan—lung cancer	0.00168	0.00168	CcSEcCtD
Clavulanate—Dermatitis—Irinotecan—lung cancer	0.00168	0.00168	CcSEcCtD
Clavulanate—Diarrhoea—Cisplatin—lung cancer	0.00166	0.00166	CcSEcCtD
Clavulanate—Vomiting—Gemcitabine—lung cancer	0.00165	0.00165	CcSEcCtD
Clavulanate—Rash—Gemcitabine—lung cancer	0.00164	0.00164	CcSEcCtD
Clavulanate—Dermatitis—Gemcitabine—lung cancer	0.00164	0.00164	CcSEcCtD
Clavulanate—Hypersensitivity—Etoposide—lung cancer	0.00164	0.00164	CcSEcCtD
Clavulanate—Haemoglobin—Doxorubicin—lung cancer	0.00163	0.00163	CcSEcCtD
Clavulanate—Hepatitis—Doxorubicin—lung cancer	0.00162	0.00162	CcSEcCtD
Clavulanate—Haemorrhage—Doxorubicin—lung cancer	0.00162	0.00162	CcSEcCtD
Clavulanate—Hypersensitivity—Paclitaxel—lung cancer	0.0016	0.0016	CcSEcCtD
Clavulanate—Nausea—Irinotecan—lung cancer	0.00158	0.00158	CcSEcCtD
Clavulanate—Pain—Docetaxel—lung cancer	0.00158	0.00158	CcSEcCtD
Clavulanate—Pruritus—Etoposide—lung cancer	0.00157	0.00157	CcSEcCtD
Clavulanate—Nausea—Gemcitabine—lung cancer	0.00154	0.00154	CcSEcCtD
Clavulanate—Vomiting—Cisplatin—lung cancer	0.00154	0.00154	CcSEcCtD
Clavulanate—Pruritus—Paclitaxel—lung cancer	0.00154	0.00154	CcSEcCtD
Clavulanate—Erythema multiforme—Doxorubicin—lung cancer	0.00153	0.00153	CcSEcCtD
Clavulanate—Rash—Cisplatin—lung cancer	0.00153	0.00153	CcSEcCtD
Clavulanate—Dermatitis—Cisplatin—lung cancer	0.00153	0.00153	CcSEcCtD
Clavulanate—Diarrhoea—Etoposide—lung cancer	0.00152	0.00152	CcSEcCtD
Clavulanate—Diarrhoea—Paclitaxel—lung cancer	0.00149	0.00149	CcSEcCtD
Clavulanate—Leukopenia—Methotrexate—lung cancer	0.00146	0.00146	CcSEcCtD
Clavulanate—Nausea—Cisplatin—lung cancer	0.00144	0.00144	CcSEcCtD
Clavulanate—Convulsion—Methotrexate—lung cancer	0.00141	0.00141	CcSEcCtD
Clavulanate—Vomiting—Etoposide—lung cancer	0.00141	0.00141	CcSEcCtD
Clavulanate—Rash—Etoposide—lung cancer	0.0014	0.0014	CcSEcCtD
Clavulanate—Dermatitis—Etoposide—lung cancer	0.0014	0.0014	CcSEcCtD
Clavulanate—Vomiting—Paclitaxel—lung cancer	0.00138	0.00138	CcSEcCtD
Clavulanate—Rash—Paclitaxel—lung cancer	0.00137	0.00137	CcSEcCtD
Clavulanate—Dermatitis—Paclitaxel—lung cancer	0.00137	0.00137	CcSEcCtD
Clavulanate—Hypersensitivity—Docetaxel—lung cancer	0.00136	0.00136	CcSEcCtD
Clavulanate—Anaphylactic shock—Methotrexate—lung cancer	0.00133	0.00133	CcSEcCtD
Clavulanate—Nausea—Etoposide—lung cancer	0.00132	0.00132	CcSEcCtD
Clavulanate—Pruritus—Docetaxel—lung cancer	0.0013	0.0013	CcSEcCtD
Clavulanate—Thrombocytopenia—Methotrexate—lung cancer	0.0013	0.0013	CcSEcCtD
Clavulanate—Nausea—Paclitaxel—lung cancer	0.00129	0.00129	CcSEcCtD
Clavulanate—Leukopenia—Doxorubicin—lung cancer	0.00126	0.00126	CcSEcCtD
Clavulanate—Diarrhoea—Docetaxel—lung cancer	0.00126	0.00126	CcSEcCtD
Clavulanate—Convulsion—Doxorubicin—lung cancer	0.00122	0.00122	CcSEcCtD
Clavulanate—Vomiting—Docetaxel—lung cancer	0.00117	0.00117	CcSEcCtD
Clavulanate—Rash—Docetaxel—lung cancer	0.00116	0.00116	CcSEcCtD
Clavulanate—Dermatitis—Docetaxel—lung cancer	0.00116	0.00116	CcSEcCtD
Clavulanate—Anaphylactic shock—Doxorubicin—lung cancer	0.00115	0.00115	CcSEcCtD
Clavulanate—Pain—Methotrexate—lung cancer	0.00114	0.00114	CcSEcCtD
Clavulanate—Thrombocytopenia—Doxorubicin—lung cancer	0.00113	0.00113	CcSEcCtD
Clavulanate—Nausea—Docetaxel—lung cancer	0.0011	0.0011	CcSEcCtD
Clavulanate—Urticaria—Methotrexate—lung cancer	0.00106	0.00106	CcSEcCtD
Clavulanate—Pain—Doxorubicin—lung cancer	0.000984	0.000984	CcSEcCtD
Clavulanate—Hypersensitivity—Methotrexate—lung cancer	0.000979	0.000979	CcSEcCtD
Clavulanate—Pruritus—Methotrexate—lung cancer	0.00094	0.00094	CcSEcCtD
Clavulanate—Urticaria—Doxorubicin—lung cancer	0.000914	0.000914	CcSEcCtD
Clavulanate—Diarrhoea—Methotrexate—lung cancer	0.000909	0.000909	CcSEcCtD
Clavulanate—Hypersensitivity—Doxorubicin—lung cancer	0.000848	0.000848	CcSEcCtD
Clavulanate—Vomiting—Methotrexate—lung cancer	0.000845	0.000845	CcSEcCtD
Clavulanate—Rash—Methotrexate—lung cancer	0.000838	0.000838	CcSEcCtD
Clavulanate—Dermatitis—Methotrexate—lung cancer	0.000837	0.000837	CcSEcCtD
Clavulanate—Pruritus—Doxorubicin—lung cancer	0.000814	0.000814	CcSEcCtD
Clavulanate—Nausea—Methotrexate—lung cancer	0.00079	0.00079	CcSEcCtD
Clavulanate—Diarrhoea—Doxorubicin—lung cancer	0.000788	0.000788	CcSEcCtD
Clavulanate—Vomiting—Doxorubicin—lung cancer	0.000732	0.000732	CcSEcCtD
Clavulanate—Rash—Doxorubicin—lung cancer	0.000726	0.000726	CcSEcCtD
Clavulanate—Dermatitis—Doxorubicin—lung cancer	0.000725	0.000725	CcSEcCtD
Clavulanate—Nausea—Doxorubicin—lung cancer	0.000684	0.000684	CcSEcCtD
